Articles From: Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 to Vertex Announces Retirement of Peter Mueller, Ph.D.


AUSTIN, Texas , July 31, 2014 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML) , a multivariate diagnostics company focused on gynecologic cancers and women's health, will hold a conference call on Thursday, August 14, 2014 , at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2014 .
Sign-up for Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 investment picks
AUSTIN, Texas , July 28, 2014 /PRNewswire/ -- Medical experts representing Vermillion, Inc. (NASDAQ: VRML) , a multivariate diagnostics company focused on gynecologic cancers and women's health, will present on ASPiRA LABS, its new CLIA-certified reference laboratory, at the American Association for Clinical Chemistry's annual (AACC) meeting on July 31 at 10 a.m. CST .
Sign-up for Vermillion to Present on ASPiRA LABS, a New Women's Health Laboratory Specializing in OVA1, at AACC investment picks
2014/8/7
As part of its ongoing effort to streamline processes in order to better serve its customers, the Vermont Department of Motor Vehicles in Montpelier announces the launch of its new Driver’s Education Certification Service - its 8 th online service in as many years.
Sign-up for Vermont: DMV Online Suite of Services Expands with New Driver’s Education Certification Service investment picks
2014/9/4
AllEarth Renewables Installing Nearly 5 Megawatts of Solar Trackers at State Facilities, Utilizing SunPower Panels WILLISTON, Vt ., Sept.
Sign-up for Vermont's Largest Public Solar Initiative Underway investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1125171&ProfileId=051205&sourceType=1 WINNERSH, UNITED KINGDOM --
Sign-up for Vernalis and Servier Achieve Research Milestone as BCL-2 Inhibitor Drug Candidate Enters Phase I investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1135178&ProfileId=051205&sourceType=1 WINNERSH, UNITED KINGDOM --
Sign-up for Vernalis and Servier Achieve Two Research Milestones in Their Oncology Collaborations investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1144422&ProfileId=051205&sourceType=1 WINNERSH, UNITED KINGDOM --
Sign-up for Vernalis PLC Announces FDA Accepts Tuzistra(TM) XR NDA for Full Review investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1131882&ProfileId=051205&sourceType=1 WINNERSH, UNITED KINGDOM --
Sign-up for Vernalis PLC: Notice of Results for the Six Months Ended 30 June 2014 investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1127673&ProfileId=051205&sourceType=1 WINNERSH, UNITED KINGDOM --
Sign-up for Vernalis PLC: Submission of TuzistraTM XR (CCP-01) NDA to FDA investment picks
2014/8/19
CALGARY , Aug.
Sign-up for Verne Johnson to Retire from Gran Tierra Energy Board of Directors investment picks
VeroLube, Inc. (“VeroLube” or the “ Company ”), announces today the signing of an extension and amendment to the previously executed stock purchase agreement dated March 10, 2014 (the “Extension”) to acquire Thermo Fluids, Inc. (“Thermo Fluids”) through its wholly owned subsidiary VeroLube USA, Inc. Thermo Fluids, a standalone subsidiary of Nuverra Environmental Solutions, Inc. (“Nuverra”) – (NYSE:NES) based in Scottsdale, Arizona, is the largest western used oil collector and the third-largest collector of used motor oil in the U.S. Thermo Fluids collects approximately 50 million gallons of used motor oil annually from a diverse base of more than 20,000 locations.
Sign-up for VeroLube’s Acquisition of Thermo Fluids Update investment picks
MERIDEN, Conn.
Sign-up for Versa Capital's Vestis Retail Group to Acquire Sport Chalet investment picks
Acquisition Expected To Provide Over $30 Million in Annualized Revenue Provides Complementary Capabilities with Strong Facilities Expertise SPRINGFIELD, Va.
Sign-up for Versar, Inc. Acquires J.M. Waller Associates investment picks
2014/9/3
SPRINGFIELD, Va.
Sign-up for Versar, Inc. Announces 4Q FY 2014 Earnings Conference Call investment picks
2014/9/10
-- Revenues for the Year Increase 7% -- --
Sign-up for Versar, Inc. Announces Fourth Quarter and Fiscal Year End 2014 Results investment picks
MENLO PARK, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- Versartis, Inc. (Nasdaq:VSAR) , an endocrine-focused biopharmaceutical company that is developing VRS-317, a novel, long-acting form of recombinant human growth hormone (rhGH) for the treatment of growth hormone deficiency (GHD), today announced it has added Bert Bakker, MD, PhD, a senior industry executive with expertise in pediatric and adult endocrinology, to its executive team as Senior Vice President, Medical Affairs.
Sign-up for Versartis Appoints Endocrinologist Bert Bakker, MD, PhD, as Senior Vice President, Medical Affairs investment picks
Long-Acting VRS-317 Efficacy and Safety Comparable to Daily Growth Hormone Therapies CHICAGO, June 23, 2014 (GLOBE NEWSWIRE) -- Versartis, Inc. (Nasdaq:VSAR) , an endocrine-focused biopharmaceutical company that is developing a novel, long-acting form of recombinant human growth hormone (rhGH), today presented positive Phase 2a data from its six month clinical trial demonstrating the safety and efficacy of VRS-317 in the treatment of naïve, pre-pubertal children with growth hormone deficiency (GHD). These results are being presented by George Bright, MD, Versartis Vice President of Clinical Development, during the clinical poster session, "Growth and GH: Diagnostic Issues and Treatment" from 1:00 – 3:00 p.m. CDT today at the 16th International Congress of Endocrinology and The Endocrine Society's 96th Annual Meeting and Expo (ICE/ENDO 2014) in Chicago, IL.
Sign-up for Versartis Presents Positive Six Month VRS-317 Phase 2a Clinical Study Results investment picks
MENLO PARK, Calif., Aug.
Sign-up for Versartis Reports Second Quarter 2014 Financial Results investment picks
MENLO PARK, Calif., Aug.
Sign-up for Versartis to Present at the Canaccord Genuity 34th Annual Growth Conference investment picks
MENLO PARK, Calif., Sept.
Sign-up for Versartis to Present at the Morgan Stanley 2014 Global Healthcare Conference investment picks
http://media.marketwire.com/attachments/201402/71180_verso.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1128457&ProfileId=051205&sourceType=1 MEMPHIS, TN --
Sign-up for Verso Commences Debt Exchange Offers investment picks
http://media.marketwire.com/attachments/201402/71180_verso.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1131886&ProfileId=051205&sourceType=1 MEMPHIS, TN --
Sign-up for Verso Paper Corp. Announces Expiration of Early Tender Time and Withdrawal Deadline for Exchange Offers and Consent Solicitations investment picks
http://media.marketwire.com/attachments/201402/71180_verso.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1137646&ProfileId=051205&sourceType=1 MEMPHIS, TN --
Sign-up for Verso Paper Corp. Reports Second Quarter 2014 Results investment picks
http://media.marketwire.com/attachments/201402/71180_verso.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1133399&ProfileId=051205&sourceType=1 MEMPHIS, TN --
Sign-up for Verso Postpones Special Meeting of Stockholders to August 12, 2014 investment picks
http://media.marketwire.com/attachments/201402/71180_verso.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1132315&ProfileId=051205&sourceType=1 MEMPHIS, TN --
Sign-up for Verso to Report Second Quarter Results and Host Conference Call on August 14 investment picks
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Peter Mueller, Ph.D., Executive Vice President of Global Research and Development and Chief Scientific Officer, will retire after more than 10 years with the company.
Sign-up for Vertex Announces Retirement of Peter Mueller, Ph.D. investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Vermillion Sets Second Quarter 2014 Conference Call for Thursday, August 14, 2014 to Vertex Announces Retirement of Peter Mueller, Ph.D.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices